Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda

摘要

IntroductionCOSTOP was a randomised controlled trial designed to assess the risks and benefits to HIV-infected participants stabilised on anti-retroviral treatment of stopping cotrimoxazole (CTX). In order to assess the extent to which patients may have had access to and used CTX other than that supplied as study drug it was decided to conduct an exit interview.